NATH BIO GENES | MONSANTO INDIA | NATH BIO GENES/ MONSANTO INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 8.7 | 23.8 | 36.8% | View Chart |
P/BV | x | 0.6 | 5.4 | 10.5% | View Chart |
Dividend Yield | % | 1.1 | 2.2 | 48.4% |
NATH BIO GENES MONSANTO INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NATH BIO GENES Mar-24 |
MONSANTO INDIA Mar-19 |
NATH BIO GENES/ MONSANTO INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 244 | 3,358 | 7.3% | |
Low | Rs | 142 | 2,424 | 5.9% | |
Sales per share (Unadj.) | Rs | 175.1 | 387.9 | 45.1% | |
Earnings per share (Unadj.) | Rs | 20.9 | 87.9 | 23.7% | |
Cash flow per share (Unadj.) | Rs | 22.6 | 94.7 | 23.8% | |
Dividends per share (Unadj.) | Rs | 2.00 | 50.00 | 4.0% | |
Avg Dividend yield | % | 1.0 | 1.7 | 59.9% | |
Book value per share (Unadj.) | Rs | 321.0 | 409.6 | 78.4% | |
Shares outstanding (eoy) | m | 19.00 | 17.26 | 110.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 7.5 | 14.8% | |
Avg P/E ratio | x | 9.3 | 32.9 | 28.1% | |
P/CF ratio (eoy) | x | 8.6 | 30.5 | 28.0% | |
Price / Book Value ratio | x | 0.6 | 7.1 | 8.5% | |
Dividend payout | % | 9.6 | 56.9 | 16.9% | |
Avg Mkt Cap | Rs m | 3,669 | 49,907 | 7.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 276 | 511 | 54.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,326 | 6,696 | 49.7% | |
Other income | Rs m | 6 | 225 | 2.8% | |
Total revenues | Rs m | 3,333 | 6,921 | 48.2% | |
Gross profit | Rs m | 534 | 1,591 | 33.6% | |
Depreciation | Rs m | 33 | 118 | 27.7% | |
Interest | Rs m | 92 | 11 | 814.6% | |
Profit before tax | Rs m | 416 | 1,687 | 24.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 19 | 170 | 11.4% | |
Profit after tax | Rs m | 396 | 1,517 | 26.1% | |
Gross profit margin | % | 16.1 | 23.8 | 67.6% | |
Effective tax rate | % | 4.7 | 10.1 | 46.4% | |
Net profit margin | % | 11.9 | 22.7 | 52.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 5,717 | 7,068 | 80.9% | |
Current liabilities | Rs m | 2,624 | 2,989 | 87.8% | |
Net working cap to sales | % | 93.0 | 60.9 | 152.6% | |
Current ratio | x | 2.2 | 2.4 | 92.1% | |
Inventory Days | Days | 65 | 318 | 20.4% | |
Debtors Days | Days | 1,035 | 6 | 18,240.3% | |
Net fixed assets | Rs m | 3,086 | 4,700 | 65.6% | |
Share capital | Rs m | 190 | 173 | 110.1% | |
"Free" reserves | Rs m | 5,909 | 6,896 | 85.7% | |
Net worth | Rs m | 6,099 | 7,069 | 86.3% | |
Long term debt | Rs m | 49 | 0 | - | |
Total assets | Rs m | 8,802 | 11,768 | 74.8% | |
Interest coverage | x | 5.5 | 150.3 | 3.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.4 | 0.6 | 66.4% | |
Return on assets | % | 5.5 | 13.0 | 42.7% | |
Return on equity | % | 6.5 | 21.5 | 30.3% | |
Return on capital | % | 8.3 | 24.0 | 34.4% | |
Exports to sales | % | 1.3 | 8.3 | 15.9% | |
Imports to sales | % | 2.3 | 19.0 | 12.1% | |
Exports (fob) | Rs m | 44 | 554 | 7.9% | |
Imports (cif) | Rs m | 76 | 1,273 | 6.0% | |
Fx inflow | Rs m | 44 | 554 | 7.9% | |
Fx outflow | Rs m | 79 | 1,430 | 5.5% | |
Net fx | Rs m | -35 | -876 | 4.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 746 | 141 | 527.9% | |
From Investments | Rs m | -274 | 709 | -38.7% | |
From Financial Activity | Rs m | -78 | -831 | 9.4% | |
Net Cashflow | Rs m | 394 | 19 | 2,096.5% |
Indian Promoters | % | 45.6 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 81.8 | - | |
Indian inst/Mut Fund | % | 4.6 | 2.4 | 188.8% | |
FIIs | % | 0.2 | 2.2 | 8.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 54.4 | 18.2 | 299.6% | |
Shareholders | 35,423 | 20,208 | 175.3% | ||
Pledged promoter(s) holding | % | 16.4 | 0.0 | - |
Compare NATH BIO GENES With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | NATH BIO GENES | MONSANTO INDIA |
---|---|---|
1-Day | 0.88% | -0.46% |
1-Month | -1.08% | 11.62% |
1-Year | -8.54% | -22.26% |
3-Year CAGR | -10.83% | -2.65% |
5-Year CAGR | -10.56% | -6.18% |
* Compound Annual Growth Rate
Here are more details on the NATH BIO GENES share price and the MONSANTO INDIA share price.
Moving on to shareholding structures...
The promoters of NATH BIO GENES hold a 45.6% stake in the company. In case of MONSANTO INDIA the stake stands at 81.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NATH BIO GENES and the shareholding pattern of MONSANTO INDIA.
Finally, a word on dividends...
In the most recent financial year, NATH BIO GENES paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.6%.
MONSANTO INDIA paid Rs 50.0, and its dividend payout ratio stood at 56.9%.
You may visit here to review the dividend history of NATH BIO GENES, and the dividend history of MONSANTO INDIA.
After opening the day marginally lower, Indian benchmark indices reversed the trend as the session progressed and ended the day higher.